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Abstract
This article revisits the epidemiology of dengue in 
Brazil, 25 years after its reemergence in the coun-
try, discussing the main determinants and im-
plications for its control. The authors emphasize 
the clinical and epidemiological peculiarities of 
this viral disease in Brazil, which leads the world 
in both the number of cases reported and risk of 
occurrence of the disease. The article presents the 
changes occurring in the dengue epidemiologi-
cal pattern in recent years, like the sudden age 
shift in the incidence of dengue hemorrhagic fe-
ver, and discusses possible associated factors. The 
article focuses specifically on the epidemic in Rio 
de Janeiro in 2008, this episode’s impact on the 
international community, and the fear that the 
disease could spread to Europe. The authors con-
clude that the current situation emphasizes the 
need for the international scientific community 
to renew its efforts to generate knowledge allow-
ing improvement and progress in the develop-
ment of new tools and strategies for dengue pre-
vention.
Aedes aegypti; Dengue; Communicable Diseases
Introduction
In the 21st century Brazil became the country of 
the world with the most reported cases of dengue 
fever, occupying first place in the international 
ranking for total cases of the disease, with more 
than three million cases reported from 2000 to 
2005. This represented 78% of all cases reported 
in the Americas and 61% of all cases reported 
to the World Health Organization (WHO) 1, 
making Brazil the country with the second to 
eighth highest risk for this disease, among coun-
tries with more than a million inhabitants 1. The 
incidence in Brazil varied from 446.3 to 63.2 per 
100 thousand inhabitants, in 2002 and 2004, re-
spectively 2.
Until the mid-1990s, Southeast Asia was the 
region of the world that was most heavily affected 
by dengue. Since then, the disease has increased 
in countries in Central and South America, 
which have contributed far more than half of the 
world’s reported cases. During the 1990s, in one 
year alone (1998), Brazil reported more than 700 
thousand cases 1.
Important differences have been observed 
in dengue epidemiology in the Americas versus 
Southeast Asia, including a lower proportion of 
cases of dengue hemorrhagic fever in the Amer-
icas within a high incidence of dengue fever 
cases 1,3. The four dengue serotypes circulate in 
the Americas, and in Brazil, DEN-1, DEN-2, and 
DEN-3 have circulated simultaneously since 
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1991. This situation, according to Halstead’s 
hypothesis of sequential infections, represents 
an important risk factor for the occurrence of 
dengue hemorrhagic fever due to the immune 
amplification phenomenon, or the formation of 
immune complexes resulting from the presence 
of antibodies to one of the dengue serotypes in 
individuals infected by a new serotype. This pro-
cess is the basis for triggering the pathophysi-
ological processes accounting for the clinical 
manifestations of dengue hemorrhagic fever 4,5.
Another difference between the two regions 
is the age bracket at highest risk. In Southeast 
Asia dengue is predominantly a childhood dis-
ease, whereas in Brazil as of 2006, the incidence 
of dengue fever, dengue hemorrhagic fever, and 
even clinically unapparent dengue virus infec-
tion was much higher in adults 6,7,8. Still, in the 
epidemic that exploded in the summer of 2008 
in Rio de Janeiro, Brazil’s second largest city, 
there was a sudden rise in the incidence among 
individuals younger than 15 years, both for den-
gue fever and dengue hemorrhagic fever 9. How-
ever, this age shift had already been occurring 
(although less visibly) in hospital admissions for 
dengue hemorrhagic fever since 2007 in Brazil 
as a whole (Sistema de Informações Hospitala-
res. http://w3.datasus.gov.br/siasih/siasih.php, 
accessed on 13/Mar/2008).
The peculiar clinical and epidemiological 
characteristics of dengue in Brazil have sparked 
the interest of Brazilian and international pub-
lic health researchers and agencies, given the 
importance of identifying the factors that deter-
mine the different forms of individual and col-
lective expression of these infections with a view 
towards improving the control and treatment of 
this viral disease, the world’s second most impor-
tant vector-borne disease in terms of number of 
cases 10.
Meanwhile, the possibility of increased oc-
currence of dengue hemorrhagic fever has 
become the object of concern for all of soci-
ety and especially for health authorities, due 
to the difficulties in controlling the epidemics 
produced by this virus and the need to expand 
the installed capacity of health services to treat 
dengue patients. A striking and very current ex-
ample is the above-mentioned epidemic in the 
city of Rio de Janeiro, which also affected other 
cities in the State of Rio de Janeiro, where in the 
first four months of 2008 alone there were more 
than 155 thousand cases of dengue fever (in-
cidence of 2,543.7/100 thousand inhabitants), 
more than 9 thousand hospitalizations, more 
than a thousand cases of dengue hemorrhagic 
fever, and 110 deaths, of which nearly half were 
children 9,11. 
Without overlooking the prevailing difficul-
ties in local health systems in Brazil, it is not 
surprising that such situations lead to a collapse 
in medical care, since the magnitude of such an 
epidemic would exceed any health system’s in-
stalled capacity. Health authorities experienced 
obvious difficulties in controlling the epidemic, 
and the situation caused panic and insecurity in 
all of Brazilian society. The episode reiterated this 
disease’s relevance as a public health problem, 
triggering great international outcry 11 and exac-
erbating institutional policy problems to respond 
adequately to the population’s needs during this 
emergency situation.
Given the complex and dynamic process in-
volving the occurrence of dengue, as evidenced 
by the rapid expansion, severity, magnitude, and 
changes in its collective and individual expres-
sion, the aim of this article is to revisit the epide-
miology of this disease 25 years after its reemer-
gence in Brazil, as well as to discuss some of the 
principal determinants and implications for its 
control.
Factors that condition the occurrence of 
dengue virus infections
According to Gubler 12 the emergence of den-
gue as a global health problem is still not fully 
understood. Evidently, the biological character-
istics of the dengue virus (four serotypes, viru-
lence of strains, sequence of infections, replica-
tion rate, etc.), host (race, age, immune system, 
etc.), and vector (reproduction rate, adaptation 
to the environment, etc.) are important factors in 
determining the incidence and severity of infec-
tions 13. Still, the population growth associated 
with unplanned and uncontrolled urbanization, 
principally in countries with a tropical climate 
creating the ideal conditions for the proliferation 
of Aedes aegypti, increased international travel 
flow, facilitating spread of the dengue virus, and 
reduction in resources for programs to control 
and prevent vector-borne infectious diseases 
contribute jointly to shaping this situation. These 
factors largely explain the international spread 
of dengue, but it is important to understand the 
dynamics of the circulation of this virus in each 
geographic and social space.  
The space human beings inhabit plays a cen-
tral role in determining the circulation of den-
gue virus serotypes and the production of den-
gue (Figure 1) 13,14. In the process of occupying 
space in modern cities, particularly in developing 
countries like Brazil, humans have created the 
conditions for the occurrence of many diseases 
and injuries 15, and in the specific case of dengue 
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these conditions are extremely favorable for its 
biological cycle (virus-vector-man). This chain is 
established in different ways in each social space, 
so that circulation of the viral serotypes occur in 
populations with different degrees of herd im-
munity, abundance of the mosquito vector, flow 
of persons, population density, turnover rate of 
susceptible individuals, and other factors that 
greatly influence the incidence and severity of 
the disease 12,16,17,18.
The force of dengue virus transmission is 
extremely high, comparable to that of transmis-
sible diseases that spread by contagion 19. Thus, 
it is no coincidence that even only 25 years since 
reemergence of dengue, Brazil has become the 
country of the world that produces the most 
cases. Based on different serological surveys in 
the country 20,21,22, important population con-
tingents already have antibodies to one or more 
of its serotypes. Brazil has broad stretches of ter-
ritory with highly favorable climate for the prolif-
eration of Ae. aegypti 23 and dozens of metropo-
lises with high human population density living 
in substandard clusters with precarious social, 
economic, and infrastructure conditions, par-
ticularly in relation to water supply and garbage 
collection. The current way of life for Brazilian 
urban populations has generated (on an expo-
nential scale) the habitats for Ae. aegypti 13,24,25 to 
lay its eggs and thus to proliferate both in areas 
with deficient sanitation and in other areas with 
adequate sanitation, thus facilitating intense vi-
ral transmission 20,21,22. 
This apparent paradox can be observed in 
Brazil through the spatial distribution of sero-
prevalence of dengue virus infections: in some 
cities, the risk is high both in neighborhoods 
with more favorable socioeconomic conditions 
and in those with precarious living conditions 
20,21,22, while in other cities the poorest popu-
lation has been hit more heavily 14,26,27. In one 
Brazilian city, the risk of dengue virus infection, 
even among residents of the same neighbor-
hood, was higher among those living in non-
vertical buildings 26.
Revisiting dengue epidemiology in Brazil
The reintroduction of Ae. aegypti in the latter 
half of the 1970s 28, in a country like Brazil with 
a tropical climate, where the environmental con-
ditions are receptive to this vector, during a pe-
riod in which entomological surveillance and the 
structure to fight the vector were nearly deacti-
vated, allowed not only its introduction in other 
strategic points but also its unchecked territorial 
expansion 13.
Although the first dengue epidemic with viral 
isolation occurred in 1981, in Boa Vista, Roraima 
State 29, it was not until 1986, when the DEN-1 
serotype was introduced into Rio de Janeiro, that 
the disease became a major public health prob-
lem. The following year, some State capitals of 
the Northeast were already affected, and the inci-
dence reached 64.6 per 100 thousand inhabitants 
(Figure 2), and the total number of accumulated 
cases reported in two years reached 134,721. 
The transmission force of the dengue virus was 
so intense that according to estimates based on 
a serological survey in 1986 and 1987 in Rio de 
Janeiro, more than a million persons had been 
infected with DEN-1 30. Since in the subsequent 
years the environmental conditions remained 
receptive to circulation of the dengue virus, in 
1990 DEN-2 was introduced, also in Rio de Ja-
neiro, with a recrudescence of dengue fever and 
the first reported cases of dengue hemorrhagic 
fever 7.
Figure 1  
Dengue: explanatory model for production of dengue virus infections.
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Beginning in 1994, circulation of the virus 
expanded to more than 600 municipalities dis-
tributed in 18 States of Brazil, with a progressive 
increase in the incidence of the disease in the 
country. In 1998, the incidence reached 345.7 
cases per 100 thousand inhabitants (Figure 2), 
and that same year dengue underwent a major 
expansion in the world 1. In 1999, some 50% of 
Brazil’s 5,507 municipalities had already report-
ed dengue fever cases and Ae. aegypti had already 
been detected in 64% of them. The proportion of 
dengue hemorrhagic fever cases in the 1990s was 
relatively low (0.06%), considering the intense si-
multaneous circulation of serotypes DEN-1 and 
DEN-2 7. 
Dengue incidence in the first two years of 
the 21st century in Brazil remained high (141.0 
and 239.4 cases per 100 thousand inhabitants 
in 2000 and 2001, respectively). With the intro-
duction of DEN-3 in 2002, there was a dramatic 
increase in both dengue fever (446.2 cases per 
100 thousand inhabitants, Figure 2) and dengue 
hemorrhagic fever, for which the reported cases 
(2,702) represented 0.34% of all reported dengue 
cases (794,219). Serotype DEN-3 spread rapidly 
to the majority of Brazilian territory, practically 
displacing serotypes DEN-1 and DEN-2 from 
various cities and States of the country in the 
subsequent years 7. 
Between 1981 and 2007, 4,463,102 cases of 
dengue were reported in Brazil (Table 1), of which 
more than three million occurred from 2000 to 
June 2007, when 72% of the country’s municipali-
ties (3,977/5,507) were already infested with Ae. 
aegypti 2. From 2000 to 2007 there was a major 
increase in the number of cases of dengue hem-
orrhagic fever (6,455), accounting for 0.21% of all 
reported dengue cases. This proportion, although 
3.5 times higher than in the 1990s, is still con-
sidered relatively low as compared to Southeast 
Asia 3. This difference has sometimes been as-
cribed to non-recognition of many dengue hem-
orrhagic fever cases by health professionals in 
Brazil 3, but if the majority of cases were really 
not being diagnosed by health services or were 
confused with some other disease, the situation 
would tend to call the attention of health authori-
ties due to the severity of this form of the disease.
Figure 2  
Dengue fever incidence rates (per 100 thousand inhabitants) according to geographic regions and year of occurrence. Brazil, 1986-2007.
Source: National Dengue Control Program 2.
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The large African descendent contingent of 
the Brazilian population, amplified by the high 
degree of racial miscegenation in various regions 
of the country, has been cited as one explana-
tion for the lower observed risk of dengue hem-
orrhagic fever in Brazil, even in the presence of a 
high dengue fever rate and the hyperendemicity 
of three dengue virus serotypes, since some case 
series studies have shown a higher frequency 
of severe forms of dengue in European descen-
dents 3,31. Recently, in Salvador, Bahia, a city 
of Brazil in which 80% of the population self-
identifies as black or mixed-race, it was shown 
for the first time that African descendent eth-
nicity confirmed by genetic markers of African 
ancestry had a protective effect against dengue 
hemorrhagic fever 32, a finding that doubtless 
strengthens the hypothesis mentioned above.
Currently, case-fatality rates below 1% for 
dengue hemorrhagic fever are considered accept-
able, but in Brazil this indicator is still extremely 
high (Figure 3), varying from 1.45% (1995) to 
11.25% (2007). Importantly, in Brazil the case-fa-
tality rate is estimated using only dengue hemor-
rhagic fever cases as the denominator, while in 
many other countries the total number of den-
gue cases is used, making comparison with these 
other countries impossible. The Brazilian health 
authorities have adopted such measures as train-
ing of health professionals, organization of health 
services during epidemic periods, and develop-
ment of public awareness campaigns on warning 
signs for the disease, aimed at early diagnosis and 
treatment of dengue hemorrhagic fever in order 
to reduce the number of fatal cases.
Until 1996, dengue virus circulation in Brazil 
was more intense in cities with more than 500 
thousand inhabitants, especially coastal State 
capitals like Rio de Janeiro, Salvador, Fortaleza, 
Recife, Natal, and others 23. A study of the first 
dengue epidemic in Salvador, capital of the State 
of Bahia, showed centrifugal propagation of cas-
es, characterizing a pattern of spread by expan-
sion with a well-defined epicenter, similar to the 
process of spread by contagion and different from 
what usually occurs with a vector-borne disease 
like dengue 19,33. A similar phenomenon may oc-
cur in the other Brazilian metropolises, inducing 
the occurrence of epidemics that propagate rap-
idly to practically the entire city, reaching signifi-
cant portions of the population.
In 1997, dengue began to occur at higher rates 
in small cities, principally those situated in the in-
terior of the North, Northeast, and Central-West, 
which correspond to the territorial stretches of 
Climatic Units that are more favorable to prolifer-
ation of Ae. aegypti (Tropical Eastern Northeast, 
Tropical Equatorial Zone, and Tropical Central 
Zone)23. This trend became even more evident in 
2007, when approximately 40% of dengue cases 
in Brazil came from municipalities with fewer 
than 100 thousand inhabitants 2.  
Although reporting of dengue fever cases 
helps detect trends in the disease, the existence 
of a considerable proportion of subclinical or un-
apparent infections means that these data alone 
do not provide a clear picture of viral circulation 
dynamics. Thus, serological surveys to determine 
the seroprevalence or seroincidence of dengue 
antibodies In order to estimate the real magni-
Table 1  
Number of municipalities (counties) with Aedes aegypti and dengue transmission, accumulated cases of dengue fever and 
dengue hemorrhagic fever, Brazil and regions, 2007 *.
 Regions Municipalities with  Municipalities with  Accumulated number of cases
  Aedes aegypti dengue transmission Dengue fever ** Dengue hemorrhagic 
     fever ***
 North 336 155 358,473 347
 Northeast 1,682 1,173 1,891,071 3,023
 Southeast 1,187 856 1,663,514 3,811
 South 323 252 93,924 12
 Central-West 449 320 456,120 674
 Brazil 3,977 2,756 4,463,102 7,867
Source: National Dengue Control Program 2.
* Data until week 51;
** Accumulated total from 1981 to 2007;
*** Accumulated total from 1990 to 2007.
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tude of these infections have been performed in 
various Brazilian cities. Such studies have shown 
that millions of Brazilians already have antibod-
ies to at least one of the dengue virus serotypes, 
and are thus at increased risk of developing den-
gue hemorrhagic fever. The mean seroprevalence 
rates have varied among the areas studied, with 
the highest rates in Mossoró (97.8%) 23, Salvador 
(67%) 20, Niterói (66%) 34, Macapá (48.4%) 23, Rio 
de Janeiro (44.5%) 30, Fortaleza (44%) 21, and São 
Luís (41.4%) 22. Lower rates were found in Goiâ-
nia (29.5%) 35, Belo Horizonte (23.3%) 26, and Ri-
beirão Preto (5.4%) 36. The variations result from 
the diversity in the distribution of determinant 
factors in each geographic space in this country 
of continental dimensions, particularly in the cli-
matic diversity and population density, in addi-
tion to the time elapsed between the initial viral 
circulation and the serological surveys, the circu-
lating serotypes, and other factors. 
Both the dengue fever and dengue hemor-
rhagic fever epidemics in Brazil had been charac-
terized by a higher incidence in the adult popula-
tion 6,7,20,21,22,37, a different pattern from that in 
most of Southeast Asia, where both forms of the 
disease are more frequent in children 38,39. How-
ever, in the first semester of 2007 there was a sud-
den change in the pattern observed in Brazil, with 
a significant increase in the proportion of dengue 
hemorrhagic fever cases in the under-15-year age 
bracket (Figure 4), especially in the Northeast. 
This phenomenon appears not to be transient, 
given the epidemic that hit Rio de Janeiro in the 
early months of 2008, when some 50% of the den-
gue fever cases and 86% of deaths occurred in 
individuals under 15 years 9. Given that during 
the 1990s in Brazil, both DEN-2 and DEN-1 cir-
culated predominantly among individuals older 
than 15 years, significant portions of the Brazil-
ian adult population currently have antibodies 
to these serotypes. Beginning in 2000-2001, with 
the introduction of DEN-3, this serotype spread 
rapidly to hundreds of Brazilian cities, with a 
near-total displacement of the previously cited 
serotypes. Since DEN-2 began predominating 
again in some cities in 2007, the currently ob-
served age shift may be due to the replenishment 
of the reserve of DEN-2 susceptible individuals, 
which began to consist of children. 
More recently, many cases of dengue hemor-
rhagic fever have been diagnosed in patients with-
out primary dengue infection, that is, individuals 
without antibodies from previous infections 37,40. 
Since such cases do not fit with the premises of 
the Halstead hypothesis of sequential infections4, 
research is needed to elucidate which other fac-
tors are involved, such as viral strain virulence, as 
reported since the 1970s 41, host genetics 32, pres-
ence of co-morbidtiy 37,39, and others that can 
contribute to dengue severity.
While the occurrence of dengue in Brazil 
displays some peculiarities, important aspects 
of its epidemiological profile have evolved in a 
similar way to that in Southeast Asia since the 
1950s, e.g., the magnitude of dengue fever epi-
demics lasting two years, followed by a reduction 
Figure 3  
Cases and deaths, dengue hemorrhagic fever, by geographic region. Brazil, 1990-2007.
3a) Cases of dengue hemorrhagic fever
3b) Deaths
Source: National Dengue Control Program 2.
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in the incidence during the following two years, 
and greater intensity of transmission during the 
hot, rainy months of the year 6,7,13,19,42,43. How-
ever, as already discussed, in Brazil the incidence 
of dengue hemorrhagic fever is lower, and until 
2006 both dengue fever and dengue hemorrhag-
ic fever occurred predominantly in adults 6,7,37. 
Atypical manifestations of dengue (neurological, 
hepatic, and cardiac, among others) have been 
described both in Brazil 37,44,45,46,47,48,49,50 and in 
other countries of the Americas and Southeast 
Asia 51, but the lack of epidemiological studies on 
their incidence does not allow comparisons.
Limits and challenges for dengue 
control
The focus for controlling dengue virus infections 
is based on fighting Ae. aegypti, due to the lack 
(to date) of safe and effective vaccines for use in 
populations. Over the course of these 25 years 
in which the Brazilian population has lived with 
dengue epidemics, the country has invested con-
siderable resources to fight the vector. The cur-
rent control program adopts an integrated mod-
el aimed at synergy of activities and obtaining 
more consistent results, as recommended by the 
WHO 52. Ten components have been developed 
simultaneously, involving not only activities to 
eliminate Ae. aegypti but also environmental 
sanitation, epidemiological and health surveil-
lance, laboratory support, and health informa-
tion and education measures, among others 53.
The current epidemiological situation with 
dengue shows that these program measures have 
not achieved success. Epidemiological impact as-
sessments of these interventions have shown that 
their effectiveness is extremely limited 20,23. Re-
gardless of each local health system’s operational 
and administrative difficulties, even when these 
measures are well managed, their effectiveness is 
always low, given the intense viral circulation de-
tected in the successive epidemics and the results 
of serological surveys conducted in various Brazi-
lian cities 6,20,21,22,23,54.
Figure 4  
Number of hospitalizations for dengue hemorrhagic fever, according to age group. Brazil, 1998-2007.
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Importantly, all the countries where the den-
gue virus circulates are facing the fact that it is 
impossible to eliminate Ae. aegypti. Even where 
programs to combat the vector have been well 
structured and the infestation rates have been 
maintained relatively low, as in Singapore and 
Cuba 38,55, the dengue virus has circulated with 
great intensity. This phenomenon is a function of 
favorable environmental conditions for prolifer-
ation and survival of this mosquito between lati-
tude 35º North and 35º South and the transmis-
sion force of the dengue virus in the presence of a 
large number of susceptible individuals 38,54,56.
Some Brazilian cities have succeeded in im-
proving the vector control program and reducing 
the domiciliary and peri-domiciliary infestation 
rates, the principal target of measures to elimi-
nate the mosquito, as in Belo Horizonte, where 
from 2003 to 2007 the mean building infestation 
rate varied from 0.3 to 0.6%, except in 2006 when 
it increased to 1.5% 2. Even so, in 2007 there was 
a sudden increase in dengue incidence in the 
city, and an entomological survey showed that 
there were also foci located outside of house-
holds (for example, in underground telephone 
installations), which possibly contributing to 
the increase in the winged Ae. aegypti popula-
tion. This vector’s adaptive capacity has been ob-
served in both the Americas and Southeast Asia, 
and as discussed above, consists of factors that 
hinder attempts to combat it. Changes have been 
observed in dengue epidemiology itself due to 
adaptation by Ae. aegypti to new environmental 
situations. In Singapore, bus stops and schools 
have apparently become the principal sites for 
acquiring dengue infections, rather than the in-
tra-domicile as previously 38.
As emphasized, prevailing contemporary 
socio-cultural factors in most human societies 
have greatly facilitated the vector’s survival and 
proliferation in human habitats, while hindering 
attempts to combat it. Such factors also contrib-
ute to the reduced effectiveness of vector control, 
the exponential growth in the number of poten-
tial breeding sites that guarantee the mosquito 
ability to lay eggs, and the hatching of larvae and 
the impossibility of establishing a comprehen-
sive struggle against the mosquito, due to the 
repetitive and exhaustive household visits. The 
population considers such visits intrusive, and 
such measures also fail to encourage individual 
responsibility in terms of environmental educa-
tion, to the extent that government implements 
certain measures in the private domain that 
should be taken by the residents themselves. 
Dengue-related educational activities in 
Brazil have been insufficiently evaluated, since 
the population absorbs the messages, but fails 
to change its practices and habits, leaving a gap 
between knowledge and behavior. The strategies 
used to transmit information may not be ade-
quate, since they have failed to result in changes 
in practices to foster the maintenance of indoor 
and outdoor household environments free of 
mosquito breeding sites 57,58,59. 
Such observations indicate the need to im-
prove or replace the vector control technolo-
gies and strategies, due to the limited scientific 
progress in this field. Research efforts have been 
made in this direction, mainly from the perspec-
tive of genetic modifications in the vector, devel-
opment of traps capable of suppressing winged 
forms 52,60,61,62,63, and the incorporation of new 
pedagogical practices favoring population be-
havior changes in relation to reduction in the 
availability of Ae. aegypti breeding sites. Environ-
mental sanitation policies are also essential to 
avoid forcing the population to store water under 
improper conditions and to ensure universal col-
lection and appropriate disposal of household 
garbage, tires, and other containers.
Final remarks
The current epidemiological situation with den-
gue in the Americas and in nearly all countries 
of the world affected by the disease has posed 
uncertainties for researchers and health officials 
concerning the magnitude and severity of future 
outbreaks of the disease. Dengue cases in travel-
ers have also raised concern among unaffected 
countries. More than a thousand non-autoch-
thonous cases of dengue have been diagnosed 
in Europe, a region still free of autochthonous 
cases. This situation has concerned the Europe-
an Community, which has warned travelers and 
developed specific surveillance and diagnostic 
systems for these individuals. Brazil ranks fifth 
among the countries that export dengue cases to 
Europe 64, a highly uncomfortable situation that 
was aggravated by the recent identification of Ae. 
albopictus in Spain 65, since it poses an additional 
problem with the international flow of persons 
from dengue-endemic and epidemic areas.
Even considering the potential protective role 
of the high proportion of African descendants in 
the Brazilian population against the emergence 
of severe forms of the disease, it is still highly 
probable that new epidemic waves of dengue 
fever will be accompanied by an increase in the 
incidence of dengue hemorrhagic fever. To the 
extent that three of four dengue virus serotypes 
are circulating (DEN-1, DEN-2, DEN-3) and that 
there is high probability that DEN-4 will be intro-
duced into the country, the prospects are for new 
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and large-scale dengue fever epidemics to occur. 
In addition, the birth cohorts will constantly re-
plenish the reserves of individuals susceptible to 
the serotypes currently circulating or that have 
circulated previously in each city, thereby favor-
ing the occurrence of other epidemics and im-
portant changes in the age and severity pattern of 
these events, as experienced in Rio de Janeiro in 
2008, regardless of the introduction of DEN-4.
Twenty-five years since the reemergence of 
dengue virus infections in Brazil, the disease 
has contributed significantly to changes in the 
country’s morbidity profile, and if the upward 
trend in the incidence of dengue hemorrhagic 
fever that began in 2002 persists, it may also 
significantly influence the country’s mortality 
profile related to infectious diseases. Although 
not a consensus 66, according to some authors, 
progressive global warming is one of the fac-
tors that has favored the reemergence and rapid 
spread of dengue, by expanding the stretches of 
territory favorable to infestation by Ae. aegypti 
67,68 and other Aedes species that could become 
competent vectors for the dengue virus. If there 
are no effective vector control alternatives to 
overcome the current technical, scientific, and 
operational difficulties, the future prospects 
are for the problem to become worse, due to an 
increase in cases of dengue hemorrhagic fever, 
especially among children. 
International initiatives have been launched 
to push the development of dengue vaccines, but 
despite the existence of some candidate vaccines, 
many difficulties are foreseen in obtaining a safe 
and effective immunogen within a reasonable 
time frame. The obstacles include characteristics 
of dengue itself, which has four serotypes, and 
the complex host immune response, which after 
infection by one of the serotypes can increase the 
risk of developing a severe form of the disease 
when the individual is infected by another sero-
type. These specificities require a vaccine that is 
simultaneously effective against all the serotypes, 
and that offers lasting immunity to rule out the 
possibility of infection by any wild virus serotype, 
due to the risk of occurrence of a severe form in 
individuals with vaccinal antibodies 69.
Given the above, the only available alterna-
tive for specific prevention to control dengue 
is still vector control, so that Brazil will need to 
make efforts to adequately implement the cur-
rently available strategies in order to enhance 
the epidemiological impact of interventions. 
Investments in research and technological de-
velopment are indispensable to improve the 
technologies to reduce or eliminate Ae. aegypti 
populations on a large scale. However, it is im-
portant to recall that dengue has its deepest roots 
in the explosive expansion of the urban environ-
ment, with a major portion of the urban popula-
tion lacking basic environmental infrastructure. 
Thus, in order for a dengue control program to 
be sustainable, it requires urban transformations 
that reduce the odds of the vector’s survival and 
which consequently decrease the transmission 
force of the virus.
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Resumo
Este artigo revisita a epidemiologia da dengue no Bra-
sil após 25 anos da sua reemergência discutindo os 
principais determinantes e implicações no seu contro-
le. Destacam-se peculiaridades clínicas e epidemioló-
gicas desta virose neste país, que ocupa uma das pri-
meiras posições no que diz respeito tanto ao número 
de casos notificados como no risco de ocorrência desta 
doença no mundo. Apresentam-se as mudanças que 
vêm ocorrendo no padrão epidemiológico da doença 
nos últimos anos, a exemplo do súbito deslocamento 
de faixa etária na incidência da febre hemorrágica 
da dengue, discutindo-se os possíveis fatores envol-
vidos. Particulariza-se a epidemia do Rio de Janeiro, 
em 2008, o reflexo deste episódio na comunidade in-
ternacional e o temor de disseminação da doença para 
a Europa. Os autores consideram que esta conjuntura 
aponta para a necessidade da comunidade científica 
mundial renovar esforços para gerar conhecimentos 
que possibilitem o aperfeiçoamento e avanço no de-
senvolvimento de novas ferramentas e estratégias de 
prevenção da dengue.
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